Monitoring and Assessing the Safety of Disease-Modifying Antirheumatic Drugs
13
Chat with Paper
AI Agents for this Paper
No abstract available for this paper.
Keywords
MedicineAdverse effectPharmacovigilanceIntensive care medicineRheumatoid arthritisPancytopeniaDiseaseInternal medicine
Chat
Click to start Chat